arrow
Back
W

William U. Shipley

Harvard Medical School

93H-index
601Paper Count
3.5WCitation Count
Published Papers 182
Publication Date
Long term results of NRG Oncology RTOG 9601, a randomized trial of radiation with or without anti-androgens (AAT) in patients receiving salvage prostate bed radiation therapy post prostatectomy
err2025-08-05
err0
PREAI
errHimanshu R. Lukka; Stephanie L. Pugh; William U. Shipley; Pierre P. Major; Oliver Sartor; Ian S. Dayes; Jean-Paul Bahary; Jason A. Efstathiou; Thomas M. Pisansky; Kenneth L. Zeitzer; Colleen A.F. Lawton; Robert T. Dess; Andrew S. Camarata; Alexander G. Balogh; Luis Souhami; Seth A. Rosenthal; J. Daniel Pennington; Wendy F. Seiferheld; Felix Y. Feng; Howard M. Sandler
errShare
errSave
Prognostic Impact of Lymph Node Yield in a Phase III Clinical Trial (NRG/RTOG 9601) of Prostate Cancer Patients Treated With Salvage Radiation Following Prostatectomy
err2025-07-21
err0
PREAI
errEmily Chan; Stephanie L. Pugh; Jeffry P. Simko; Felix Feng; William U. Shipley; Himanshu R. Lukka; Jean-Paul Bahary; Thomas M. Pisansky; Kenneth Lee Zeitzer; Elizabeth Gore; Jason A. Efstathiou; Seth A. Rosenthal; Alexander G. Balogh; Richard D. Lovett; Anthony Wong; Robert T. Dess; L. Scott McGinnis; Michael Kuettel; Luda DeMora; Howard M. Sandler
errShare
errSave
Long-Term Results of Bladder Preservation With Twice-Daily Radiation Plus 5-Fluorouracil/ Cisplatin or Daily Radiation Plus Gemcitabine for Muscle-Invasive Bladder Cancer-Updated Report of NRG/RTOG 0712: A Randomized Phase 2 Trial
err2025-01-01
err0
PREAI
errCoen, John J.; Rodgers, Joseph P.; Saylor, Philip J.; Lee, Cheryl T.; Wu, Chin-Lee; Parker, William; Lautenschlaeger, Tim; Zietman, Anthony L.; Efstathiou, Jason; Jani, Ashesh B.; Kucuk, Omer; Souhami, Luis; Pugh, Stephanie L.; Sandler, Howard M.; Shipley, William U.
errShare
errSave
Cardiovascular Mortality and Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-term Update of NRG/RTOG 9202
err2024-03-01
err3
PREAI
errMak, Kimberley S.; Bryan, Molly Scannell; Dignam, James J.; Shipley, William U.; Lin, Yue; Peters, Christopher A.; Gore, Elizabeth M.; Rosenthal, Seth A.; Zeitzer, Kenneth L.; D'Souza, David P.; Horwitz, Eric M.; Pisansky, Thomas M.; Maier, Jordan M.; Chafe, Susan M.; Robin, Tyler P.; Roach III, Mack; Tran, Phuoc T.; Souhami, Luis; Michalski, Jeff M.; Hartford, Alan C.; Feng, Felix Y.; Sandler, Howard M.; Efstathiou, Jason A.
errShare
errSave
Long-term Outcomes of Chemoradiation for Muscle-invasive Bladder Cancer in Noncystectomy Candidates. Final Results of NRG Oncology RTOG 0524-A Phase 1/2 Trial of Paclitaxel plus Trastuzumab with Daily Radiation or Paclitaxel Alone with Daily Irradiation
err2024-02-01
err0
PREAI
errDahl, Douglas M.; Karrison, Theodore G.; Michaelson, M. Dror; Pham, Huong T.; Wu, Chin-Lee; Swanson, Gregory P.; Shipley, William U.; Vuky, Jacqueline; Lee, R. Jeffrey; Zietman, Anthony L.; Souhami, Luis; Chang, Brian K.; Deming, Richard L.; Ellerton, John A.; Sandler, Howard M.; Rodgers, Joseph P.; Feng, Felix Y.; Efstathiou, Jason A.
errShare
errSave
Analysis of a Biopsy-Based Genomic Classifier in High-Risk Prostate Cancer: Meta-Analysis of the NRG Oncology/Radiation Therapy Oncology Group 9202, 9413, and 9902 Phase 3 Randomized Trials
err2023-07-01
err23
errOAAI
errNguyen, Paul L.; Huang, Huei-Chung (Rebecca); Spratt, Daniel E.; Davicioni, Elai; Sandler, Howard M.; Shipley, William U.; Efstathiou, Jason A.; Simko, Jeffry P.; Pollack, Alan; Dicker, Adam P.; Roach III, Mack; Rosenthal, Seth A.; Zeitzer, Kenneth L.; Mendez, Lucas C.; Hartford, Alan C.; Hall, William A.; Desai, Anand B.; Rabinovitch, Rachel A.; Peters, Christopher A.; Rodgers, Joseph P.; Tran, Phuoc; Feng, Felix Y.
errShare
errSave
Adding Short-Term Androgen Deprivation Therapy to Radiation Therapy in Men With Localized Prostate Cancer: Long-Term Update of the NRG/RTOG 9408 Randomized Clinical Trial
err2022-02-01
err21
errOAAI
errJones, Christopher U.; Pugh, Stephanie L.; Sandler, Howard M.; Chetner, Michael P.; Amin, Mahul B.; Bruner, Deborah W.; Zietman, Anthony L.; Den, Robert B.; Leibenhaut, Mark H.; Longo, John M.; Bahary, Jean-Paul; Rosenthal, Seth A.; Souhami, Luis; Michalski, Jeff M.; Hartford, Alan C.; Amin, Pradip P.; Roach, Mack; Yee, Don; Efstathiou, Jason A.; Rodgers, Joseph P.; Feng, Felix Y.; Shipley, William U.
errShare
errSave
Complications and Outcomes of Salvage Cystectomy after Trimodality Therapy
err2021-07-01
err17
PREAI
errPieretti, Alberto; Krasnow, Ross; Drumm, Michael; Gusev, Andrew; Dahl, Douglas M.; McGovern, Francis; Blute, Michael L.; Shipley, William U.; Efstathiou, Jason A.; Feldman, Adam S.; Wszolek, Matthew F.
errShare
errSave
Two Years of Anti-Androgen Treatment Increases Other-Cause Mortality in Men Receiving Early Salvage Radiotherapy: A Secondary Analysis of the NRG Oncology/RTOG 9601 Randomized Phase III Trial
err2019-11-01
err12
PREAI
errSpratt, D. E.; Dess, R. T.; Efstathiou, J. A.; Zietman, A. L.; Wallington, D. G.; Jairath, N. K.; Jackson, W. C.; Den, R. B.; Stish, B. J.; Morgan, T. M.; Dignam, J. J.; Pisansky, T. M.; Rosenthal, S. A.; Michalski, J. M.; Sartor, O.; Feng, F. Y.; Schipper, M.; Sandler, H. M.; Sun, Y.; Shipley, W. U.
errShare
errSave
Impact of Immune and Stromal Infiltration on Outcomes Following Bladder-Sparing Trimodality Therapy for Muscle-Invasive Bladder Cancer
err2019-07-01
err113
errOAAI
errEfstathiou, Jason A.; Mouw, Kent W.; Gibb, Ewan A.; Liu, Yang; Wu, Chin-Lee; Drumm, Michael R.; da Costa, Jose Batista; du Plessis, Marguerite; Wang, Natalie Q.; Davicioni, Elai; Feng, Felix Y.; Seiler, Roland; Black, Peter C.; Shipley, William U.; Miyamoto, David T.
errShare
errSave
MicroRNA Biomarkers for Patients With Muscle-Invasive Bladder Cancer Undergoing Selective Bladder-Sparing Trimodality Treatment
err2019-05-01
err20
PREAI
errMeng, Wei; Efstathiou, Jason; Singh, Rajbir; McElroy, Joseph; Volinia, Stefano; Cui, Ri; Ibrahim, Ahmed; Johnson, Benjamin; Gupta, Nirmala; Mehta, Satvam; Wang, Huabao; Miller, Eric; Phuong Nguyen; Fleming, Jessica; Wu, Chin-Lee; Haque, S. Jaharul; Shipley, William; Chakravarti, Arnab
errShare
errSave
Androgen Receptor Activity and Radiotherapeutic Sensitivity in African-American Men with Prostate Cancer: A Large Scale Gene Expression Analysis and Meta-Analysis of RTOG Trials
err2018-11-01
err17
PREAI
errSpratt, D. E.; Dess, R. T.; Hartman, H. E.; Mahal, B. A.; Jackson, W. C.; Soni, P. D.; Alshalalfa, M.; Fishbane, N.; Zumsteg, Z. S.; Shipley, W. U.; Pisansky, T. M.; Roach, M., III; Zhao, S. G.; Speers, C.; Davicioni, E.; Schipper, M.; Nguyen, P. L.; Schaeffer, E. M.; Feng, F. Y.; Sandler, H. M.
errShare
errSave
Comparative Effectiveness of Bladder-Preserving Tri-Modality Therapy versus Radical Cystectomy for Muscle-Invasive Bladder Cancer
err2018-11-01
err0
PREAI
errRoyce, T. J.; Feldman, A. S.; Mossanen, M.; Yang, J. C.; Shipley, W. U.; Pandharipande, P. V.; Efstathiou, J. A.
errShare
errSave
Long-Term Update of NRG Oncology RTOG 94-08
err2018-11-01
err4
PREAI
errJones, C. U.; Pugh, S.; Sandler, H. M.; Chetner, M. P.; Amin, M.; Efstathiou, J. A.; Den, R. B.; Leibenhaut, M. H.; Longo, J. M.; Bahary, J. P.; Rosenthal, S. A.; Souhami, L.; Michalski, J. M.; Hartford, A. C.; Amin, P. P.; Roach, M., III; Yee, D.; Rodgers, J.; Shipley, W. U.
errShare
errSave
Randomized phase 2 trial of radiation with either gemcitabine or 5FU/cisplatin in bladder cancer
err2018-04-01
err0
errOAAI
errShipley, W. U.; Zhang, P.; Saylor, P.; Lee, C.; Wu, C. L.; Parker, W.; Lautenschlaeger, T.; Zietman, A.; Efstathiou, J.; Jani, A.; Kucuk, O.; Souhami, L.; Rodgers, J.; Sandler, H.; Coen, J.
errShare
errSave
Incidence, Clinicopathological Risk Factors, Management and Outcomes of Nonmuscle Invasive Recurrence after Complete Response to Trimodality Therapy for Muscle Invasive Bladder Cancer
err2018-02-01
err35
PREAI
errSanchez, Alejandro; Wszolek, Matthew F.; Niemierko, Andrzej; Clayman, Rebecca H.; Drumm, Michael; Rodriguez, Dayron; Feldman, Adam S.; Dahl, Douglas M.; Heney, Niall M.; Shipley, William U.; Zietman, Anthony L.; Efstathiou, Jason A.
errShare
errSave
Selective Bladder Preservation with Twice-Daily Radiation Plus 5-Flourouracil/Cisplatin or Daily Radiation Plus Gemcitabine for Patients with Muscle Invasive Bladder Cancer-Primary Results of NRG/RTOG 0712: A Randomized Phase 2 Multicenter Trial
err2017-12-01
err1
PREAI
errCoen, J. J.; Zhang, P.; Saylor, P. J.; Lee, C. T.; Wu, C. L.; Parker, W.; Lautenschlaeger, T.; Zietman, A. L.; Efstathiou, J. A.; Jani, A.; Souhami, L.; Kucuk, O.; Rodgers, J.; Sandler, H. M.; Shipley, W. U.
errShare
errSave
Subtyping Muscle-Invasive Bladder Cancer to Assess Clinical Response to Trimodality Therapy
err2017-10-01
err1
errOAAI
errEfstathiou, J. A.; Gibb, E.; Miyamoto, D. T.; Wu, C. L.; Drumm, M. R.; Lehrer, J.; Ashab, H. A. D. M.; Erho, N. G.; du Plessis, M.; Ong, K.; Bhat, A.; Mouw, K.; Davicioni, E.; Shipley, W. U.
errShare
errSave
The Impact of MRE11 in Nuclear to Cytoplasmic Ratio on Outcomes in Muscle Invasive Bladder Cancer: an Analysis of NRG/RTOG 8802, 8903, 9506, 9706, 9906, and 0233.
err2017-10-01
err4
errOAAI
errMagliocco, A.; Moughan, J.; Simko, J.; Efstathiou, J. A.; Gray, P. J.; Hagan, M.; Kaufman, D.; Tester, W.; Zietman, A. L.; McCarthy, S.; Hartford, A. C.; Patel, A. B., Jr.; Rosenthal, S. A.; McGowan, D. G.; Greenberg, R.; Schwartz, M. S.; Augspurger, M.; Keech, J.; Winter, K.; Shipley, W. U.
errShare
errSave
Outcomes and Tolerability of Selective Bladder Preservation by Combined Modality Therapy for Invasive Bladder Cancer in Elderly Patients
err2017-10-01
err2
PREAI
errMiyamoto, D. T.; Drumm, M. R.; Clayman, R. H.; Niemierko, A.; Heney, N.; Lee, R.; Zietman, A. L.; Shipley, W. U.; Efstathiou, J. A.
errShare
errSave